Tender detail

Conclusion of a Non-Exclusive Discount Agreement for Medicinal Products Containing Dapagliflozin

Summary

The tender concerns the conclusion of non-exclusive pharmaceutical discount agreements for medicinal products containing the active substance dapagliflozin (ATC A10BK01). The agreements are intended to run from 1 October 2026 to 30 September 2028, but will end automatically if an exclusive agreement for the substance enters into force. Interested pharmaceutical companies may participate, and the bidder must identify the relevant medicinal products in the contract annex. Precise exclusion, qualification and compliance requirements must be checked in the official tender documents.

Reference number
571195-2026
Buyer
DAK-Gesundheit
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2028-07-29
Status
Open
Contract subject
Supplies
Estimated value
1,00 EUR
Source
TED

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.